Literature DB >> 33399327

Management of Central Venous Access in Children With Intestinal Failure: A Position Paper From the NASPGHAN Intestinal Rehabilitation Special Interest Group.

Danielle Wendel1, Ethan A Mezoff2, Vikram K Raghu3, Sivan Kinberg4, Jason Soden5, Yaron Avitzur6, Jeffrey A Rudolph3, Michelle Gniadek2, Valeria C Cohran7, Robert S Venick8, Conrad R Cole9.   

Abstract

ABSTRACT: Intestinal failure requires the placement and maintenance of a long-term central venous catheter for the provision of fluids and/or nutrients. Complications associated with this access contribute to significant morbidity and mortality, while the loss of access is an increasingly common reason for intestinal transplant referral. As more emphasis has been placed on the prevention of central line-associated bloodstream infections and new technologies have developed, care for central lines has improved; however, because care has evolved independently in local centers, care of central venous access varies significantly in this vulnerable population. The present position paper from the Intestinal Failure Special Interest Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) reviews current evidence and provides recommendations for central line management in children with intestinal failure.
Copyright © 2020 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Entities:  

Year:  2021        PMID: 33399327     DOI: 10.1097/MPG.0000000000003036

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  Immunosuppression Regimens for Intestinal Transplantation in Children.

Authors:  Vikram Kalathur Raghu; Carol G Vetterly; Simon Peter Horslen
Journal:  Paediatr Drugs       Date:  2022-05-23       Impact factor: 3.022

2.  Anthropometrics and fat mass, but not fat-free mass, are compromised in infants requiring parenteral nutrition after neonatal intestinal surgery.

Authors:  Lotte E Vlug; Esther G Neelis; Jonathan C K Wells; Mary S Fewtrell; Wendy L M Kastelijn; Joanne F Olieman; Marijn J Vermeulen; Jorine A Roelants; Dimitris Rizopoulos; René M H Wijnen; Edmond H H M Rings; Barbara A E de Koning; Jessie M Hulst
Journal:  Am J Clin Nutr       Date:  2022-02-09       Impact factor: 7.045

Review 3.  Dilemmas in feeding infants with intestinal failure: a neonatologist's perspective.

Authors:  Amy B Hair; Misty Good
Journal:  J Perinatol       Date:  2022-09-20       Impact factor: 3.225

4.  Significant Published Articles in 2021 for Pharmacy Nutrition Support Practice.

Authors:  Roland N Dickerson; Angela L Bingham; Todd W Canada; Lingtak Neander Chan; M Petrea Cober; Sarah V Cogle; Anne M Tucker; Vanessa J Kumpf
Journal:  Hosp Pharm       Date:  2022-06-04

Review 5.  Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure.

Authors:  Renz C W Klomberg; Lotte E Vlug; Barbara A E de Koning; Lissy de Ridder
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.569

Review 6.  Difficult Vascular Access in Children with Short Bowel Syndrome: What to Do Next?

Authors:  Chiara Grimaldi; Francesca Gigola; Kejd Bici; Chiara Oreglio; Riccardo Coletta; Antonino Morabito
Journal:  Children (Basel)       Date:  2022-05-09

7.  Spectrum of Interventional Procedures During Hybrid Central Line Placement in Pediatric Intestinal Rehabilitation Patients With End-Stage Vascular Access.

Authors:  Ludger Sieverding; Jörg Michel; Christian Urla; Ekkehard Sturm; Franziska Winkler; Michael Hofbeck; Jörg Fuchs; Johannes Hilberath; Steven Walter Warmann
Journal:  Front Nutr       Date:  2022-03-28

Review 8.  Infection Prevention and Management in Pediatric Short Bowel Syndrome.

Authors:  Laura Merras-Salmio; Mikko P Pakarinen
Journal:  Front Pediatr       Date:  2022-06-30       Impact factor: 3.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.